Description

In this episode, Renslow Sherer, MD, discusses managing a first ART failure in the setting of COVID-19, including:

• Guideline recommendations for resistance testing
• Guideline recommendations for selecting a new ART regimen
• Data on retained efficacy of NRTIs in second-line regimens in the EARNEST and NADIA studies
• Consideration of drug‒drug interactions between ART and COVID-19 treatment

Presenter: 
Renslow Sherer, MD
Director 
International HIV Training Center 
Professor of Medicine 
Section of Infectious Diseases and Global Health 
Department of Medicine 
University of Chicago 
Chicago, Illinois 

To download the slides: https://bit.ly/3OcqxIE 

To view the full online program: https://bit.ly/3ZjSFhg

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.